A receptor protein that shows up on cancerous colon cells might serve as a new target for scientists seeking to derail this malignancy. A study in mice shows that shutting down the receptor slows cancer growth.
The receptor protein is called neuropilin-2 (NRP2). Earlier work hinted that it facilitates the activity of a family of proteins called vascular endothelial growth factors (VEGF), which dock onto other cell receptors.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.